Sanofi Reinforces Commitment as Africa Becomes Free of Wild Poliovirus

The independent Africa Regional Certification Commission (ARCC), the body responsible for certifying the eradication of wild poliovirus in the WHO Africa Region (WHO-Afro), has granted the region ‘wild poliovirus free’ status.

This follows after Nigeria, the last wild poliovirus endemic country in the region, recorded no new cases in three years–the requisite period–since it last reported cases of wild poliovirus.

Sanofi Pasteur, the world’s single largest producers of vaccines, is proud to be associated with this major milestone for Nigeria, WHO Africa Region and the overall global efforts to free the world of polio.

In Nigeria, Sanofi Pasteur has been working in collaboration with stakeholders such as the National Primary Healthcare Development Agency (NPHCDA), WHO, UNICEF and several multi-lateral and non-governmental organizations in the national immunization programmes for children under 5 years ofage.

Charles Wolf, Vaccines Head for Africa, said:“The ambition to eradicate polio from the world has been a long journey. The recent declaration by ARCC certifying the WHO Africa region as free of wild poliovirus is a watershed for the WHO and all partners in the Global Polio Eradication Initiative (GPEI).For over three decades, we at Sanofi Pasteur have been supporting the global public health coalition on polio through our  expertise and the provision of innovative vaccines to support national, regional and global immunization programs for children under 5 years of age”.

Polio is a highly infectious viral disease that is transmitted from person to person, mainly through a fecal- oral route or, less frequently, through contaminated water or food and multiplies inside the intestines. Onein200infectionsleadstoirreversibleparalysis,usually in the legs.

Amongthoseparalyzed,5 to 10 per cent diewhentheirbreathingmusclesbecomeimmobilized.Poliomainlyaffectschildrenunder5yearsofage.

There is no cure for polio but the disease can be prevented through administration of a simple and effective vaccine, given multiple times. This is why efforts are underway across every country to rapidly boost immunity levels in children and protect them from polio paralysis.

Wild poliovirus cases have decreased by over 99 per cent since 1988, from an estimated 350,000 cases in more than125 endemic countries then to 33 reported cases in2018. Of the three strains of wild poliovirus (type1, type2andtype3), wild polio virus type2 was eradicated in 1999 and no case of wild polio virus type3 has been found since the last reported case in Nigeria in November2012.

In 1988, the Global Polio Eradication Initiative (GPEI) was launched by several stakeholders involved in global public health and led by the World Health Organization. At that time, polio was endemic in 125 countries with more than 350,000 children paralyzed each year. Since then, thanks to the strong collaborations across the GPEI, there has been a 99.9% decrease in paralytic cases.

The fight against polio worldwide is not yet over. Sanofi Pasteur remains committed to supporting the GPEI until the disease is eradicated worldwide. Once polio is eradicated, the world can celebrate the delivery of a major global public good that will benefit all people equally, no matter where they live. By then, no child will ever again suffer the terrible effects of lifelong polio-paralysis.

spot_img
spot_img
spot_img
spot_img
spot_img

Hot this week

Fidelity Bank Targets Growth for SMEs at Abuja Business Forum

Fidelity Bank Plc will conclude its 2026 Quarterly Business...

NEM Group Chairman, Tope Smart, to KEYNOTE Business Journal Insurance & Pension Roundtable 2026

Mr. Tope Smart, Group Chairman, NEM Insurance Group will...

Top10 Magazine Names Umaru Kwairanga as Man of the Year 2026

Alhaji (Dr) Umaru Kwairanga, Group Chairman, Nigerian Exchange Group...

CBN Grants JPMorgan Approval-in-Principle to Establish Merchant Bank in Nigeria

The Central Bank of Nigeria (CBN) has granted Approval-in-Principle...

Cardoso Engages Business Leaders on Strengthening Nigeria–China Financial Corridor

The Central Bank of Nigeria (CBN) convened a high-level...

Topics

NCC Rolls Out Measures to Support Stakeholders on COVID-19

Prof. Umar Danbatta Executive Vice-Chairman NCC As the COVID-19, better known as...

Interswitch: Value Financing Will Spur Growth of Payment Ecosystem

Africa’s leading integrated payments and digital commerce company, Interswitch,...

Kogi State to Host GOCOP 2024 Conference on Power, Insecurity, Digital Economy

The Guild of Corporate Online Publishers (GOCOP) will hold...

Ecobank Partners Ogun State on Agric, Empowerment, Health

Ogun State Governor, Prince Dapo Abiodun (r) and...

Kenya, 1st Country to Launch ‘Novartis Access’ for Affordable Health

Novartis has announced the launch of Novartis Access in Kenya, the first country to benefit from a portfolio of 15 affordable medicines to treat cardiovascular diseases, diabetes, respiratory illnesses, and breast cancer. The Novartis portfolio is being offered to the Kenyan government, non-governmental organisations and other public-sector healthcare providers for USD 1 per treatment, per month.

Linkage Assurance Pays N2.7bn Claims, Focuses on Profitability

Linkage Assurance Plc says it will take advantage of...

How AfCFTA Could Catalyse Africa’s Untapped Agric Sector

Louis van Ravesteyn Pan-Africa Head of Agribusiness, Personal and...

Financial Inclusion and The Rise of Payment

By Elvis Eromosele Technology is an almost indispensable part of...
spot_img

Related Articles

Popular Categories

spot_imgspot_img